Europe Malaria Diagnostics Market

Europe Malaria Diagnostics Market Size (2023 to 2028)

The malaria diagnostics market size in Europe is estimated to be valued at USD 350 million by 2028 from USD 270 million in 2023, growing at a CAGR of 5.4% from 2023 to 2028.

The growing number of malaria cases reported in the European region primarily propel the Europe malaria diagnostics market growth. As per the statistics published by statista.com, an estimated 4.8 thousand malaria cases were reported in the European Union in 2021. Malaria is primarily transmitted through female Anopheles mosquito bites and does not spread directly between individuals. Factors such as unhygienic surroundings and drainage issues contribute to the proliferation of mosquitoes in the area. Symptoms of malaria include fever, sweating, headaches, muscle pain, and vomiting. Timely detection of malaria in patients facilitates prompt treatment and helps prevent further transmission of the infection by local mosquitoes.

The rising demand for diagnostic tools specifically designed for malaria detection further fuels the growth rate of the Europe malaria diagnostics market. Malaria diagnostic tests play a crucial role in identifying the presence of malaria parasites in affected individuals. Microscopy is commonly employed to examine a drop in the patient's blood and detect the presence of these parasites. Manufacturers have developed various point-of-care tests to facilitate the detection of malaria among patients. These diagnostic tools play a vital role in enabling accurate and timely diagnosis contribute to the European market growth.

The growing awareness among the European population about the importance of early diagnosis and treatment of malaria, ongoing research and development efforts are leading to the introduction of innovative diagnostic solutions and rising investments by key stakeholders in the malaria diagnostics sector propel the European market growth. Collaborative efforts by international organizations, such as WHO and CDC and growing improvements in the healthcare infrastructure across Europe further promote the European market growth.

Limited awareness among the general population about the importance of malaria diagnostics and high costs associated with malaria diagnostic tests primarily hamper the growth of the European malaria diagnostics market. Insufficient healthcare infrastructure, including diagnostic facilities and laboratories in some parts of Europe, poor access to healthcare facilities and diagnostic services in remote and rural areas and the shortage of skilled healthcare professionals and laboratory technicians trained in malaria diagnostics limits the growth rate of the European market. Stringent regulatory requirements and approval processes for diagnostic tests and insufficient funding for malaria diagnostics research and development further impede the European market growth.

This research report on the Europe malaria diagnostics market has been segmented and sub-segmented into the following categories.

By Technology:

• Microscopy
• Rapid Diagnostic Tests
• Molecular Diagnostic Tests

By End User:

• Hospitals
• Clinics
• Diagnostics Centers
• Others

By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Europe is a promising regional market for malaria diagnostics and accounted for a noteworthy share of the global market in 2022.

The France is anticipated to account for a substantial share of the European market in the coming years owing to the growing number of awareness programs and rapid adoption of advanced diagnostic devices. The government of France implemented measures to conduct awareness programs and provide diagnostic kits to local hospitals.

The UK is predicted to hold a considerable share of the European market during the forecast period. Factors such as the high mortality rate from malaria, a notable presence of clinical trial facilities for malaria vaccine and drug development, attracting pharmaceutical companies' support drives the growth of the UK market.

Germany is estimated to register a healthy CAGR during the forecast period. The presence of numerous manufacturing facilities and increasing malaria cases among children and growing awareness among the population regarding disease occurrence and diagnostic tests propel the German market growth.

KEY MARKET PLAYERS:

Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, bioMérieux SA and BD are a fe of the major players in the Europe malaria diagnostics market.